₹-0.10
(Market cap
₹207 Cr
Recently Viewed
Clear AllMarket cap
₹207 Cr
Revenue (TTM)
₹2 Cr
P/E Ratio
70.7
P/B Ratio
2.5
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹3 Cr
ROE
6.7 %
ROCE
9.1 %
Industry P/E
47.69
EV/EBITDA
48
Debt to Equity
0
Book Value
₹66.6
EPS
₹2.4
Face value
10
Shares outstanding
12,240,000
CFO
₹-16.35 Cr
EBITDA
₹6.49 Cr
Net Profit
₹37.04 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Transchem
| -7.5 | 9.4 | 0.4 | 322.4 | 102.6 | 55.0 | 25.8 |
|
BSE Healthcare
| 0.4 | 5.5 | 5.6 | 2.2 | 24.1 | 13.3 | 10.8 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Transchem
| 270.1 | 89.5 | -10.1 | -1.0 | 35.7 | 43.4 | -44.4 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Transchem
|
169.4 | 207.3 | 2.4 | 2.9 | -116.5 | 3.7 | 70.7 | 2.5 |
| 2,395.0 | 19,609.0 | 1,215.1 | 284.8 | 28.7 | 21.1 | 68.3 | 12.9 | |
| 751.1 | 14,763.9 | 7,266.8 | 627.5 | 11.9 | 12.6 | 23.5 | 2.7 | |
| 360.1 | 13,795.4 | 2,051.5 | 180.5 | 11.6 | 7.7 | 68.4 | 3.6 | |
| 689.5 | 17,075.7 | 5,092.5 | 545.5 | 15.9 | 14.1 | 31.3 | 3.9 | |
| 1,093.2 | 19,566.9 | 4,560.2 | 1,544.6 | 35.1 | 19.2 | 12.6 | 2.2 | |
| 1,824.3 | 20,796.8 | 1,419.3 | 20.1 | 8.4 | 0.5 | 1034.6 | 3.6 | |
| 165.5 | 21,992.4 | 8,871.4 | -223.5 | 1.9 | -1.6 | -- | 2.8 | |
| 421.2 | 16,971.8 | 3,720.2 | 352.1 | 13.7 | 8.2 | 48.2 | 3.6 | |
| 1,405.2 | 22,831.0 | 3,151.0 | -10.0 | 8.4 | 2.5 | 1037.8 | 4.9 |
No Review & Analysis are available.
Transchem Limited does not have significant operations. Previously, it was engaged in the production of mushrooms. Transchem Limited was incorporated in 1976 and is based in Thane, India.
Incorporated
1976
Chairman
Sejal Jain
Managing Director
--
Headquarters
Mumbai, Maharashtra
Website
Looking for more details about Transchem Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of Transchem Ltd is ₹169.35 (BSE) and ₹4.25 (NSE) as of 24-Apr-2026 IST. Transchem Ltd has given a return of 102.65% in the last 3 years.
The P/E ratio of Transchem Ltd is 70.75 times as on 24-Apr-2026, a 48 premium to its peers’ median range of 47.69 times.
The P/B ratio of Transchem Ltd is 2.54 times as on 24-Apr-2026, a 30 discount to its peers’ median range of 3.63 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
7.80
|
0.51
|
|
2024
|
8.17
|
0.45
|
|
2023
|
18.71
|
0.35
|
|
2022
|
9.39
|
0.41
|
|
2021
|
0.85
|
0.32
|
The 52-week high and low of Transchem Ltd are Rs 194.25 and Rs 35.20 as of 24-Apr-2026.
Transchem Ltd has a market capitalisation of ₹ 207 Cr as on 24-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Transchem Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.